Over its decades in existence, the ADRC has accumulated a rare and valuable body of resources. These include detailed pathological, clinical, neuroimaging, genetic information; and biospecimens,
The ADRC has established a Resource Committee whose goal is to aid investigators in accessing and utilizing the resources and in fostering new research.
Any investigator interested in utilizing such resources must complete the web-based ADRC Resource Request and the Resource Committee will review for approval. The committee member most relevant to a particular research question will contact investigators. Acceptance of ADRC data and/or materials obligates the recipient to cite/reference the NIA grants supporting this project. The ADRC is supported by the National Institutes of Health, through Grant Number P30AG066462.
In addition to resources available directly from the ADRC database and biospecimen resource systems, the ADRC has committed to facilitating access to resources available from two other major Columbia University projects with a focus on Alzheimer’s disease: WHICAP and EFIGA. Requests for resources from these projects are available below.
To submit a request, please click the link to a project-specific resource request form below:
ADRC Resource Request Form: Beginning in 1989, the Alzheimer’s Disease Research Center (ADRC) has recruited patients from Columbia University Medical Center, affiliated clinics, and nursing homes in the New York area. Patients receive a rigorous annual clinical evaluation and autopsies are performed on those from whom prior consent has been obtained.
WHICAP Resource Request Form: The Washington-Heights/Inwood Columbia Aging project (WHICAP) is a community-based longitudinal study, recruiting elderly subjects from Northern Manhattan. Cohorts were established in 1992, 1999 and 2009. Subjects are evaluated every two years.
EFIGA Resource Request Form: Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) is a study based on a cohort of Caribbean Hispanics with Late Onset Alzheimer’s Disease recruited from clinics in the Dominican Republic and New York.